(NCT03015922) Interestingly, it has also been shown the PD-1/PD-L1 blockade in MM be enhanced with lenalidomide by further attenuating MDSC-mediated immune suppression and abrogating bone marrow stromal cell-induced MM growth27. The gene discussed is CD274; the disease is Miyoshi myopathy.